Flynn James E 13D/13G Filings for Cogent Biosciences, Inc. (COGT)

Flynn James E 13D and 13G filings for Cogent Biosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-02-10
09:40 am
Sale		 2022-12-31 13G Cogent Biosciences, Inc.
COGT		 Flynn James E 2,966,345
4.240%		 -2,910,460decrease
(-49.52%)		 Filing
2022-06-17
08:00 am
Purchase		 2022-06-13 13G Cogent Biosciences, Inc.
COGT		 Flynn James E 5,876,805
9.640%		 5,876,805increase
(New Position)		 Filing